上海南方模式生物科技股份有限公司关于回购股份集中竞价减持股份进展公告

Core Viewpoint - The company, Shanghai Southern Model Biological Technology Co., Ltd., has announced the progress of its share repurchase and subsequent reduction plan, indicating a commitment to maintaining shareholder value and adhering to regulatory requirements [1][2]. Summary by Sections Share Repurchase Overview - The company repurchased a total of 788,912 shares from February 23, 2024, to May 22, 2024, which accounts for 1.0119% of its total share capital. The repurchased shares are intended to maintain company value and shareholder rights, with plans to sell them within 12 months after the announcement of the repurchase results [1]. Reduction Plan Progress - On August 29, 2025, the company disclosed a plan to reduce up to 779,635 shares (not exceeding 1% of total share capital) through centralized bidding within three months following the announcement. The reduction will be adjusted if there are changes in share capital due to dividends or other corporate actions [2][3]. Implementation Status of Reduction Plan - As of September 30, 2025, the company has not yet reduced any of the repurchased shares. The company is required to disclose the progress of the reduction plan within the first three trading days of each month [4]. Other Relevant Matters - There are no significant changes to the previously disclosed reduction plan, and no major corporate actions such as high bonus shares or mergers have been announced during the reduction period [3][4].